The use of pan-retinal photocoagulation to treat recurrent vitreous haemorrhage with neovascularisation in the context of Epstein syndrome: an MYH9-related disorder
- PMID: 31888892
- PMCID: PMC6936552
- DOI: 10.1136/bcr-2019-231710
The use of pan-retinal photocoagulation to treat recurrent vitreous haemorrhage with neovascularisation in the context of Epstein syndrome: an MYH9-related disorder
Abstract
A female patient presented with stable chronic thrombocytopaenia with large platelets, sensorineuronal deafness and renal impairment. Her treatment was refractory to intravenous immunoglobulins (IVIG) and steroids for a putative diagnosis of immune thrombocytopaenic purpura (ITP). She underwent genetic testing which revealed a MYH9 mutation in-keeping with a diagnosis of Epstein Syndrome. Subsequently to this she developed globally constricted fields on Goldmann visual field testing. MRI pituitary was unremarkable but she was diagnosed with a pituitary microprolactinoma secondary to raised prolactin in the blood responsive to carbegoline therapy. She subsequently developed retinal haemorrhages and recurrent vitreous haemorrhages due to neovascularisation. Fluorescein angiography revealed the extent of the neovascularisation and microvascular ischaemia. She underwent pan-retinal photocoagulation (PRP) to treat the ischaemic stimulus which resulted in regression of the new vessels and cessation of vitreous haemorrhages. There are no previous reported cases of microvascular retinal disease in the literature in the context of Epstein Syndrome, and this is the first report of successful treatment with PRP.
Keywords: Haematology (incl blood transfusion); Ophthalmology; Retina.
© BMJ Publishing Group Limited 2019. No commercial re-use. See rights and permissions. Published by BMJ.
Conflict of interest statement
Competing interests: None declared.
Figures



Similar articles
-
MYH9 Associated nephropathy.Nefrologia (Engl Ed). 2019 Mar-Apr;39(2):133-140. doi: 10.1016/j.nefro.2018.08.008. Epub 2018 Nov 22. Nefrologia (Engl Ed). 2019. PMID: 30471777 Review. English, Spanish.
-
A De Novo Mutation in MYH9 in a Child With Severe and Prolonged Macrothrombocytopenia.J Pediatr Hematol Oncol. 2021 Jan;43(1):e7-e10. doi: 10.1097/MPH.0000000000001846. J Pediatr Hematol Oncol. 2021. PMID: 32520844
-
Familial cases with MYH9 disorders caused by MYH9 S96L mutation.Pediatr Int. 2013 Feb;55(1):102-4. doi: 10.1111/j.1442-200X.2012.03619.x. Pediatr Int. 2013. PMID: 23409987
-
Familial macro thrombocytopenia: role of genetics where morphology fails.Blood Coagul Fibrinolysis. 2020 Jul;31(5):333-334. doi: 10.1097/MBC.0000000000000923. Blood Coagul Fibrinolysis. 2020. PMID: 32516168
-
Massive subretinal and vitreous haemorrhages at presentation in idiopathic thrombocytopenic purpura: report of a case and review of literature.Clin Exp Optom. 2014 May;97(3):270-3. doi: 10.1111/cxo.12072. Epub 2013 Jun 13. Clin Exp Optom. 2014. PMID: 23763572 Review.
References
-
- Savoia A, Pecci A. MYH9-Related Disorders : Adam MP, Ardinger HH, Pagon RA, GeneReviews® [Internet]. Seattle, WA: University of Washington, 1993. - PubMed
-
- Hu R, Hao J, Yang H, et al. . Fechtner syndrome, a nonmuscle myosin heavy chain 9 gene mutation related disease: a case report and literature review]. Zhonghua Xue Ye Xue Za Zhi Zhonghua Xueyexue Zazhi 2011;32:103–6. - PubMed
-
- Furlano M, Arlandis R, del Prado Venegas M, et al. . Myh9 associated nephropathy. Nefrología 2019;39:133–40. - PubMed
Publication types
MeSH terms
Substances
Supplementary concepts
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous